|

ENV-294 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 2: 1

Top Sponsors

  • Enveda Therapeutics1

Indications

  • Asthma1

Birmingham, Alabama1 trial

ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults

AllerVie Clinical Research

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.